TONYA FLAKUS: Open Payments
NPI 1649916529 · ELKHORN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$193 in 11 payments from 8 companies in 2025. Trend: 2023 $230 · 2024 $160 · 2025 $193
Food & beverage: $193
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 3 | $46 |
| ABBVIE INC. | 1 | $35 |
| Novo Nordisk Inc | 2 | $34 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $18 |
| SANOFI-AVENTIS U.S. LLC | 1 | $18 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $14 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
| AstraZeneca Pharmaceuticals LP | 1 | $13 |
Products named: MOUNJARO, QULIPTA, Wegovy, TZIELD, Ozempic, Kerendia, REXULTI.
Industry payments across NE — which companies pay providers there.
